Fulltext

Bridging glycated hemoglobin with quality of life and health state; a randomized case-control study among type 2 diabetes patients

Gillani SW 1 , Ansari IA 2 , Zaghloul HA 1 , Abdul MIM 1 , Sulaiman SAS 3 , Baig MR 4

Affiliations 

  • 1 1Department of Clinical & Hospital Pharmacy, College of Pharmacy, Taibah University, PO Box: 41411, Al-Madinah Al Munawarrah, Saudi Arabia
  • 2 2Department of Pathology, College of Medicine, Taibah University, Al-Madinah Al Munawarrah, Kingdom of Saudi Arabia
  • 3 3School of Pharmaceutical Sciences, Universiti Sains Malaysia (USM), Penang, Malaysia
  • 4 4Dubai Pharmacy College, Dubai, UAE
Diabetol Metab Syndr, 2018;10:23.
PMID: 29610581 DOI: 10.1186/s13098-018-0325-6

Abstract

Background: The aim of this study was to explore the predictors of QOL and health state and examine the relationship with glycemic control among type 2 diabetes mellitus (T2DM) patients.
Methods: A randomized cross-sectional case-control study was conducted among n = 600 T2DM patients of Malaysia. Study population was distributed into three groups as: controls: patients with HbA1c ≤ 7 (n = 199), cases arm 1: with HbA1c 7-7.9 (n = 204) and cases arm 2 (n = 197): with HbA1c ≥ 8 consecutively last 3 times.
Results: Participants with diabetes history > 10 years exhibits higher mean QOL score among all the three groups. In contrast mean health status score significantly (p 

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications